Comparing Treatments for HIV-Infected Opioid Users in an Integrated Care Effectiveness Study (CHOICES) Scale-Up

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

February 5, 2018

Primary Completion Date

November 8, 2019

Study Completion Date

November 8, 2019

Conditions
Opioid-use DisorderHiv
Interventions
DRUG

Naltrexone Injectable Suspension

Six monthly injections of extended-release naltrexone

OTHER

Treatment as usual

Standard treatment for opioid use disorder provided at each HIV clinic

Trial Locations (5)

21287

Johns Hopkins University, Bartlett Specialty Clinic, Baltimore

33136

Jackson Memorial Hospital, Miami

40536

University of Kentucky Bluegrass Care Clinic, Lexington

60612

Ruth M. Rothstein CORE Center, Chicago

91356

Tarzana Treatment Centers, Tarzana

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

Johns Hopkins University

OTHER

collaborator

University of Kentucky

OTHER

collaborator

Jackson Health System

OTHER

collaborator

Tarzana Treatment Centers

OTHER

collaborator

Ruth M. Rothstein CORE Center

OTHER

lead

Oregon Health and Science University

OTHER

NCT03275350 - Comparing Treatments for HIV-Infected Opioid Users in an Integrated Care Effectiveness Study (CHOICES) Scale-Up | Biotech Hunter | Biotech Hunter